Advertisement
Home 2017 March

Monthly Archives: March 2017

In a clinical practice guideline published in the March issue of Otolaryngology-Head and Neck Surgery

Guidelines Updated for Benign Paroxysmal Positional Vertigo

0
Recommendations for diagnosis, management of BPPV based on data from reviews, randomized trials
For patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL)

Blinatumomab Linked to Longer Survival in Adults With ALL

0
Significantly longer overall, event-free survival for relapsed, refractory B-cell precursor ALL
An 11-factor index predicts 10- and 14-year mortality with excellent calibration and discrimination among community-dwelling U.S. adults aged ≥65 years

Index Predicts 10-, 14-Year Mortality in Older Adults

0
Eleven-factor index predicts mortality with excellent calibration and discrimination
For patients with BRAF wild-type metastatic melanoma

Cost-Effectiveness Compared for Metastatic Melanoma Treatments

0
First-line pembrolizumab or nivolumab followed by second-line ipilumumab most cost-effective
There is moderate interobserver agreement among glaucoma specialists using two glaucoma progression software packages

Moderate Interobserver Agreement for Glaucoma Software

0
Moderate agreement for visual field and OCT glaucoma progression software packages
A new treatment for dust mite allergies has been approved by the U.S. Food and Drug Administration.

FDA Approves Odactra for House Dust Mite Allergies

0
Year-round, once-a-day tablet that's taken sublingually
Among American adults 20 and older

Rate of Hearing Loss Projected to Almost Double in the U.S. by 2060

0
Increase will be greatest among adults over 70, researchers say
For patients with head and neck cancer

Speech Pathology Telepractice Beneficial in Head, Neck Cancer

0
Higher service efficiency, drop in number, duration of contact events needed to manage referrals
Patients with nonsteroidal anti-inflammatory drug (NSAID)-induced urticaria/angioedema may develop tolerance to NSAIDs over time

Tolerance Develops in NSAID-Induced Urticaria/Angioedema

0
Patients confirmed as having NIUA develop tolerance to NSAIDs over time
The characteristics of the signal in user feedback of adverse events associated with medical devices and the situated context of decision makers correlate with judgement bias in reacting to these adverse events

Judgement Bias in Medical Device Recall Decisions

0
Decision makers in firms either over-react or under-react, researchers say